NCT02478164 Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma Status COMPLETED Phase PHASE2
NCT02473484 Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas Status COMPLETED Phase N/A
NCT02466828 qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia. Status COMPLETED Phase EARLY_PHASE1
NCT02465268 Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT02458508 Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy Status COMPLETED Phase N/A
NCT02457845 HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors Status COMPLETED Phase PHASE1
NCT02455557 SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02432417 The Addition of Chloroquine to Chemoradiation for Glioblastoma, Status WITHDRAWN Phase PHASE2
NCT02431572 A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy Status COMPLETED Phase NA
NCT02430363 Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 Status UNKNOWN Phase PHASE1/PHASE2
NCT02410577 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme Status COMPLETED Phase NA
NCT02394665 Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma Status TERMINATED Phase PHASE2
NCT02379572 Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas Status COMPLETED Phase NA
NCT02375841 Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02372409 Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors Status TERMINATED Phase PHASE2